Acta Med. 2008, 51: 107-112
https://doi.org/10.14712/18059694.2017.11
Expression of Bcl-2 in Breast Cancer: Correlation with Clinicopathological Characteristics and Survival
Crossref Cited-by Linking
- Hu Xue, Yang Zihui, Liu Wenjing, Pan Zhaohai, Zhang Xin, Li Minjing, Liu Xiaona, Zheng Qiusheng, Li Defang: The Anti-tumor Effects of p-Coumaric Acid on Melanoma A375 and B16 Cells. Front. Oncol. 2020, 10. <https://doi.org/10.3389/fonc.2020.558414>
- Mansouri Hidaya, Mnango Leah F., Magorosa Erick P., Sauli Elingarami, Mpolya Emmanuel A.: Ki-67, p53 and BCL-2 Expressions and their Association with Clinical Histopathology of Breast Cancer among Women in Tanzania. Sci Rep 2019, 9. <https://doi.org/10.1038/s41598-019-46184-x>
- Noguero Meseguer M. Rosario, Yago Lisbona Laura, Segovia Blázquez Beatriz, Muñoz Díez M. Mar, Martín Gutiérrez Silvia, Carpintero Franco Ruth, Sancho Pérez Blanca, Gallego Alvarez Marta, Sanz Ferrández M. Consuelo, Mendizábal Urízar Jose Luis: Valor pronóstico de los receptores hormonales, receptor del factor de crecimiento epidérmico humano, ciclinas D1 y D2, B-Cell Lymphoma2 y ciclooxigenasa-2 en pacientes jóvenes con cáncer de mama. Progresos de Obstetricia y Ginecología 2013, 56, 242. <https://doi.org/10.1016/j.pog.2012.07.010>
